Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 million
Pharma major Sun Pharmaceutical informed that it has entered into an agreement to acquire 16.7 per cent stake in the US-based Lyndra Therapeutics for $30...
Continue ReadingLupin introduces triple combination Vilfuro-G in India for COPD
Pharmaceutical company Lupin has introduced the fixed-dose triple combination (FDC) drug, Vilfuro-G, to manage chronic obstructive pulmonary disease (COPD) in India.Lupin’s Vilfuro-G blends fluticasone furoate,...
Continue ReadingDr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index
Dr. Reddy’s has become the first Indian pharma company to earn a place in the Standard & Poor Dow Jones Sustainability World Index (DJSI World)...
Continue ReadingLupin Receives Approval from U.S. FDA for Varenicline Tablets
Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...
Continue ReadingU.S. FDA nod for Zydus Lifesciences’ generic injection
Zydus Lifesciences has received U.S. Food and Drug Administration final approval to manufacture and market Methylene Blue Injection, 10mg/2ml and 50mg/5ml.A generic version of reference...
Continue ReadingKaruna Therapeutics’ NDA for KarXT accepted by USFDA
Karuna Therapeutics has announced that U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for KarXT (xanomeline-trospium) for the treatment of...
Continue ReadingBharat Biotech, University of Sydney ink MoU for vaccine research
Bharat Biotech International and the University of Sydney Infectious Diseases Institute (Sydney ID) entered into a Memorandum of Understanding (MoU) to advance vaccine research initiatives.It...
Continue ReadingAurobindo unit gets USFDA nod to market generic asthma medication
Aurobindo Pharma on November 30 said its subsidiary has received approval from the U.S. health regulator to market a generic medication to treat asthma in...
Continue ReadingDr Reddy’s launches wearable therapy device for migraine
Dr. Reddy’s Laboratories launched Nerivio, a state-of-the-art United States Food and Drug Administration (USFDA) approved wearable therapy device for drug-free management of migraine, in the...
Continue Reading